Literature DB >> 2405319

Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios.

G Mari1, K J Moise, R L Deter, B Kirshon, R J Carpenter.   

Abstract

To investigate the effects of indomethacin on the human fetal renal blood flow velocity waveform, 17 fetuses whose mothers were treated for preterm labor (N = 8) or polyhydramnios (N = 9) were studied. There were five growth-retarded fetuses (all in the group with polyhydramnios), 11 normal fetuses, and one fetus with red-cell alloimmunization. The indomethacin dose in all patients was 25 mg orally every 6 hours. The gestational age of the fetuses studied varied between 24-35 weeks (mean +/- SD 29.6 +/- 2.8). The fetal renal artery was studied at its origin from the aorta before and during the first 24 hours of indomethacin therapy. Seven fetuses manifested ductal constriction. Three fetuses also manifested tricuspid regurgitation. All ductal constrictions and the tricuspid regurgitations resolved in utero after discontinuation of indomethacin. There were no significant differences in the pulsatility index values of the renal artery before and during indomethacin therapy. These results suggest that there is no change in fetal renovascular parameters detectable with pulsatility index measurements during the first 24 hours of maternal indomethacin therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405319

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Renal Artery Doppler Findings in the Patients with Polyhydramnios before and after the Conservative Treatment.

Authors:  Melek Akdogan; Ali İpek; Aydın Kurt; Aslı Tanrıvermis Sayit; Mustafa Karaoglanoglu
Journal:  Eurasian J Med       Date:  2015-06

2.  Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents.

Authors:  B S Kaplan; I Restaino; D S Raval; R P Gottlieb; J Bernstein
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.